<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01892670</url>
  </required_header>
  <id_info>
    <org_study_id>2012/2279</org_study_id>
    <nct_id>NCT01892670</nct_id>
  </id_info>
  <brief_title>Storage Temperature and Quality of Leucoreduced Whole Blood</brief_title>
  <acronym>BFF</acronym>
  <official_title>Storage Temperature and Quality of Leucoreduced Whole Blood</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Haukeland University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Norwegian Armed Forces Medical Service</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Haukeland University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In a combat situation the need for safe and high-quality blood products is increasing. WB
      (Whole Blood) is used in many trauma situations, but we wish to investigate whether there is
      an even better whole blood product.

      The purpose of this study is to examine the quality of leucoreduced, cold-stored whole blood.
      We also wish to examine the effects of filtration of whole blood without a 1-2 hour
      holding-time (warm-filtration) and the effects of forced filtration. We also wish to explore
      the possibility of using cold-stored WB for production of RCC.

      Analyses are performed with a main focus to investigate function and quality of red blood
      cells and platelets.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Platelet function</measure>
    <time_frame>After 10 days of cold-storage</time_frame>
    <description>Platelet function is assessed by various parameters, such as thrombelastography (TEG), Multiplate and flow cytometry (Lactadherin, Calcein violet AM, ++).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Leukocyte count</measure>
    <time_frame>After leukocyte filtration</time_frame>
    <description>Filtered whole blood should have a concentration less than 1*10^6 cells/L to avoid transfusion reactions.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Hemolysis</measure>
    <time_frame>After 42 days of storage</time_frame>
    <description>RCC should not have a hemolysis of more than 0.8 %. We investigate this up to 42 days (35 days as RCC) (arm 5 +6)</description>
  </other_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">87</enrollment>
  <condition>Trauma</condition>
  <condition>Austere Environment</condition>
  <condition>Blood Bank</condition>
  <condition>Buddy Transfusion</condition>
  <arm_group>
    <arm_group_label>Filtered whole blood</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Leukocyte-reduced whole blood, 2 hours holding-time after collection. Gravitational filtration.
Device: Terumo IMUFLEX WB(Whole blood)-SP(saving platelets) collection bag system</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Unfiltered whole blood</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Non-leukocyte-reduced whole blood, 2 hours holding-time after collection.
Device: Terumo IMUFLEX WB-SP collection bag system</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Warm-filtered whole blood</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Leukocyte-reduced whole blood, no holding-time after collection. Gravitational filtration.
Device: Terumo IMUFLEX WB-SP collection bag system</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Forced warm-filtration of whole bood</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Leukocyte-reduced whole blood, no holding-time after collection. Forced filtration.
Device: Terumo IMUFLEX WB-SP collection bag system</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RCC produced from cold-stored whole blood</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>RCC production from 7 days old, cold-stored, leukocyte-reduced whole blood. Units stored for another 35 days. (42 days of storage in total).
Devices: Terumo IMUFLEX WB-SP/WB-RP collection bag systems.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RCC produced from cold-stored non-filtered whole blood</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>RCC production from 7 days old, cold-stored, non-leukocyte-reduced whole blood. Units stored for another 35 days. (42 days of storage in total).
Devices: Terumo IMUFLEX WB-SP/WB-RP(removing platelets) collection bag systems.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Donation of 1 whole blood unit</intervention_name>
    <description>Donation of 450-500 mL of whole blood according to local blood bank procedures and national guidelines.</description>
    <arm_group_label>Filtered whole blood</arm_group_label>
    <arm_group_label>Unfiltered whole blood</arm_group_label>
    <arm_group_label>Warm-filtered whole blood</arm_group_label>
    <arm_group_label>Forced warm-filtration of whole bood</arm_group_label>
    <arm_group_label>RCC produced from cold-stored whole blood</arm_group_label>
    <arm_group_label>RCC produced from cold-stored non-filtered whole blood</arm_group_label>
    <other_name>Terumo IMUFLEX WB-SP collection bag system.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy volunteer

          -  Age between 18 and 70

          -  Negative pregnancy test (women in fertile age)

          -  Blood pressure range: (160-100)/(100-40)

          -  Pulse range: 40-100

        Exclusion Criteria:

          -  Usage of platelet-influencing medication

          -  Mild flu or more severe illnesses

          -  Open wound

          -  Pregnancy or trying to get pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Geir Strandenes, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Haukeland University Hospital and Norwegian Naval Special Operation Commando</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Haukeland University Hospital, Dept of Immunology and Transfusion Medicine</name>
      <address>
        <city>Bergen</city>
        <zip>5021</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <link>
    <url>http://rdcr.org/</url>
    <description>THOR: Trauma Hemostasis and Oxygenation Research Network. Main objective: To reduce the risk of death from traumatic hemorrhagic shock prior to admission at a trauma center</description>
  </link>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 1, 2013</study_first_submitted>
  <study_first_submitted_qc>July 1, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 4, 2013</study_first_posted>
  <last_update_submitted>August 8, 2017</last_update_submitted>
  <last_update_submitted_qc>August 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Blood</keyword>
  <keyword>Whole blood</keyword>
  <keyword>Cold-storage</keyword>
  <keyword>Filtration</keyword>
  <keyword>Transfusion</keyword>
  <keyword>Platelet-function</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

